1. Home
  2. MREO vs TRC Comparison

MREO vs TRC Comparison

Compare MREO & TRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • TRC
  • Stock Information
  • Founded
  • MREO 2015
  • TRC 1843
  • Country
  • MREO United Kingdom
  • TRC United States
  • Employees
  • MREO N/A
  • TRC N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • TRC Real Estate
  • Sector
  • MREO Health Care
  • TRC Finance
  • Exchange
  • MREO Nasdaq
  • TRC Nasdaq
  • Market Cap
  • MREO 424.5M
  • TRC 463.5M
  • IPO Year
  • MREO N/A
  • TRC N/A
  • Fundamental
  • Price
  • MREO $2.85
  • TRC $16.55
  • Analyst Decision
  • MREO Strong Buy
  • TRC
  • Analyst Count
  • MREO 7
  • TRC 0
  • Target Price
  • MREO $7.71
  • TRC N/A
  • AVG Volume (30 Days)
  • MREO 1.2M
  • TRC 104.4K
  • Earning Date
  • MREO 08-12-2025
  • TRC 08-05-2025
  • Dividend Yield
  • MREO N/A
  • TRC N/A
  • EPS Growth
  • MREO N/A
  • TRC 298.28
  • EPS
  • MREO N/A
  • TRC 0.08
  • Revenue
  • MREO N/A
  • TRC $42,689,000.00
  • Revenue This Year
  • MREO N/A
  • TRC $0.64
  • Revenue Next Year
  • MREO $54.07
  • TRC N/A
  • P/E Ratio
  • MREO N/A
  • TRC $207.56
  • Revenue Growth
  • MREO N/A
  • TRC 7.04
  • 52 Week Low
  • MREO $1.58
  • TRC $14.71
  • 52 Week High
  • MREO $5.02
  • TRC $19.82
  • Technical
  • Relative Strength Index (RSI)
  • MREO 64.74
  • TRC 53.63
  • Support Level
  • MREO $2.61
  • TRC $16.06
  • Resistance Level
  • MREO $2.85
  • TRC $16.55
  • Average True Range (ATR)
  • MREO 0.17
  • TRC 0.36
  • MACD
  • MREO 0.03
  • TRC 0.04
  • Stochastic Oscillator
  • MREO 88.83
  • TRC 77.12

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About TRC Tejon Ranch Co

Tejon Ranch Co is a diversified real estate development and agribusiness company committed to responsibly using its land and resources to meet the housing, employment, and lifestyle needs of Californians and create value for its shareholders. It has five segments namely Real Estate - Commercial/Industrial, Real Estate - Resort/Residential, Mineral Resources, Farming, and Ranch Operations.

Share on Social Networks: